Human Milk Oligosaccharides Market to exceed $1.5 bn by 2032, Says Global Market Insights Inc.
January 10, 2024 18:30 ET
|
Global Market Insights Inc.
Selbyville, Delaware, Jan. 10, 2024 (GLOBE NEWSWIRE) -- The human milk oligosaccharides market valuation is anticipated to cross USD 1.5 billion by 2032, as reported in a research study by Global...
Global Synbiotic Product Market Soars to Reach US$ 1,116.9 Million by 2033 Addressing the Rising Demand for Gut Health | Future Market Insights, Inc.
November 02, 2023 03:30 ET
|
Future Market Insights Global and Consulting Pvt. Ltd.
NEWARK, Del, Nov. 02, 2023 (GLOBE NEWSWIRE) -- The synbiotic product market size is valued at US$ 638.2 million in 2023. The 2022 valuation was US$ 598.2 million. The market is expected to progress...
GreenLight Biosciences Enters into Definitive Merger Agreement with Consortium Led by Fall Line Endurance Fund for Go-Private Transaction
May 30, 2023 07:01 ET
|
GreenLight Biosciences
LEXINGTON, Mass., May 30, 2023 (GLOBE NEWSWIRE) -- GreenLight Biosciences Holdings, PBC (NASDAQ: GRNA) (“GreenLight” or the “Company”) today announced that the Company has entered into a definitive...
GreenLight Biosciences Releases Inaugural Sustainability Report
April 12, 2023 06:59 ET
|
GreenLight Biosciences
BOSTON, April 12, 2023 (GLOBE NEWSWIRE) -- GreenLight Biosciences (Nasdaq: GRNA), a public benefit corporation striving to deliver on the full potential of RNA to address some of the world’s...
Prebiotics Market to Hit USD 20.89 Billion by 2030 owing to Growing Interest in Plant-Based Diets Globally
March 16, 2023 09:30 ET
|
SNS Insider pvt ltd
Pune, March 16, 2023 (GLOBE NEWSWIRE) -- According to SNS Insider, the growth of the prebiotics market is also driven by the increasing prevalence of digestive disorders such as irritable bowel...
Sale of Flow Cytometry and Imaging Business From DiaSorin to Cytek® Biosciences Completed
February 28, 2023 09:21 ET
|
Cytek Biosciences, Inc.
SALUGGIA, Italy, and FREMONT, Calif., Feb. 28, 2023 (GLOBE NEWSWIRE) -- DiaSorin (FTSE MIB: DIA) and Cytek Biosciences, Inc. (Nasdaq: CTKB) today announced that Luminex Corporation, a wholly...
GreenLight Biosciences receives approval to initiate Phase I/II clinical trial of Covid-19 mRNA vaccine candidate
February 01, 2023 07:20 ET
|
GreenLight Biosciences
The Rwanda FDA has given regulatory approval to GreenLight to start a Phase I/II clinical trial of its Covid-19 vaccine candidate in Rwanda. This phase I/II clinical trial is the first step in...
Prebiotics Market Research Report by Ingredients, Application, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19
December 07, 2022 08:44 ET
|
ReportLinker
New York, Dec. 07, 2022 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Prebiotics Market Research Report by Ingredients, Application, Region - Global Forecast to 2027 -...
New funding announced to upgrade Canada’s biocontainment facilities
November 16, 2022 17:00 ET
|
Canada Foundation for Innovation
OTTAWA, Nov. 16, 2022 (GLOBE NEWSWIRE) -- The COVID-19 pandemic taught us that to tackle emerging global health issues countries must remain at the forefront of research. In Canada, this includes...
Cytek® Biosciences Names Chris Williams Chief Operating Officer
October 31, 2022 16:30 ET
|
Cytek Biosciences, Inc.
Experienced Biotech, Pharmaceutical Industry Leader to Guide Operations Growth and Scalability FREMONT, Calif., Oct. 31, 2022 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq: CTKB) today...